Red Blood Cell Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Red Blood Cell stocks.

Red Blood Cell Stocks Recent News

Date Stock Title
Nov 1 TEVA Teva long-acting olanzapine shows improvements in schizophrenia patients
Nov 1 TEVA Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition
Nov 1 TEVA Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well ...
Nov 1 TEVA Countdown to Teva Pharmaceutical Industries (TEVA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Nov 1 TEVA EC fines Teva $502m over multiple sclerosis treatment Copaxone practices
Nov 1 CERS Cerus Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Nov 1 AMGN Amgen Third Quarter 2024 Earnings: EPS Beats Expectations
Oct 31 CERS Q3 2024 Cerus Corp Earnings Call
Oct 31 AMGN Amgen earns higher revenues in Q3 2024, puts rare diseases in the spotlight
Oct 31 AMGN Q3 2024 Amgen Inc Earnings Call
Oct 31 AMGN Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO
Oct 31 TEVA Teva fined $500M by EU for disparaging rival MS drug (update)
Oct 31 TEVA EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
Oct 31 TEVA Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns
Oct 31 AMGN Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus
Oct 31 TEVA Teva Statement on European Commission Decision; Company to Appeal
Oct 31 CERS Cerus Corp (CERS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Oct 31 AMGN Amgen Inc (AMGN) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Pipeline ...
Oct 31 CERS Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript
Oct 31 AMGN Amgen Inc. (AMGN) Q3 2024 Earnings Call Transcript
Red Blood Cell

Red blood cells, also known as RBCs, red cells, red blood corpuscles, haematids, erythroid cells or erythrocytes (from Greek erythros for "red" and kytos for "hollow vessel", with -cyte translated as "cell" in modern usage), are the most common type of blood cell and the vertebrate's principal means of delivering oxygen (O2) to the body tissues—via blood flow through the circulatory system. RBCs take up oxygen in the lungs, or gills of fish, and release it into tissues while squeezing through the body's capillaries.
The cytoplasm of erythrocytes is rich in hemoglobin, an iron-containing biomolecule that can bind oxygen and is responsible for the red color of the cells and the blood. The cell membrane is composed of proteins and lipids, and this structure provides properties essential for physiological cell function such as deformability and stability while traversing the circulatory system and specifically the capillary network.
In humans, mature red blood cells are flexible and oval biconcave disks. They lack a cell nucleus and most organelles, in order to accommodate maximum space for hemoglobin; they can be viewed as sacks of hemoglobin, with a plasma membrane as the sack. Approximately 2.4 million new erythrocytes are produced per second in human adults. The cells develop in the bone marrow and circulate for about 100–120 days in the body before their components are recycled by macrophages. Each circulation takes about 60 seconds (one minute). Approximately a quarter of the cells in the human body are red blood cells. Nearly half of the blood's volume (40% to 45%) is red blood cells.
Packed red blood cells (pRBC) are red blood cells that have been donated, processed, and stored in a blood bank for blood transfusion.

Browse All Tags